SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-045057
Filing Date
2023-12-15
Accepted
2023-12-15 16:30:19
Documents
12
Period of Report
2023-12-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46308
  Complete submission text file 0001493152-23-045057.txt   221532

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sonn-20231215.xsd EX-101.SCH 3018
3 XBRL LABEL FILE sonn-20231215_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE sonn-20231215_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3328
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 231490786
SIC: 2834 Pharmaceutical Preparations